Biological Sciences, College of Arts and Sciences, Texas Tech University, Lubbock, TX, USA.
IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute, Badalona, Spain.
Autophagy. 2021 Feb;17(2):553-577. doi: 10.1080/15548627.2020.1725401. Epub 2020 Feb 25.
Macroautophagy/autophagy is an auto-digestive pro-survival pathway activated in response to stress to target cargo for lysosomal degradation. In recent years, autophagy has become prominent as an innate antiviral defense mechanism through multiple processes, such as targeting virions and viral components for elimination. These exciting findings have encouraged studies on the ability of autophagy to restrict HIV. However, the role of autophagy in HIV infection remains unclear. Whereas some reports indicate that autophagy is detrimental for HIV, others have claimed that HIV deliberately activates this pathway to increase its infectivity. Moreover, these contrasting findings seem to depend on the cell type investigated. Here, we show that autophagy poses a hurdle for HIV replication, significantly reducing virion production. However, HIV-1 uses its accessory protein Nef to counteract this restriction. Previous studies have indicated that Nef affects autophagy maturation by preventing the fusion between autophagosomes and lysosomes. Here, we uncover that Nef additionally blocks autophagy initiation by enhancing the association between BECN1 and its inhibitor BCL2, and this activity depends on the cellular E3 ligase PRKN. Remarkably, the ability of Nef to counteract the autophagy block is more frequently observed in pandemic HIV-1 and its simian precursor SIV infecting chimpanzees than in HIV-2 and its precursor SIV infecting sooty mangabeys. In summary, our findings demonstrate that HIV-1 is susceptible to autophagy restriction and define Nef as the primary autophagy antagonist of this antiviral process. 3-MA: 3-methyladenine; ACTB: actin, beta; ATG16L1: autophagy related 16 like 1; BCL2: bcl2 apoptosis regulator; BECN1: beclin 1; cDNA: complementary DNA; EGFP: enhanced green fluorescence protein; ER: endoplasmic reticulum; Gag/p55: group-specific antigen; GFP: green fluorescence protein; GST: glutathione S transferase; HA: hemagglutinin; HIV: human immunodeficiency virus; IP: immunoprecipitation; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; Nef: negative factor; PRKN: parkin RBR E3 ubiquitin ligase; PtdIns3K: phosphatidylinositol 3 kinase; PtdIns3P: phosphatidylinositol 3 phosphate; PTM: post-translational modification; RT-qPCR: reverse transcription followed by quantitative PCR; RUBCN: rubicon autophagy regulator; SEM: standard error of the mean; SERINC3: serine incorporator 3; SERINC5: serine incorporator 5; SIV: simian immunodeficiency virus; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; UVRAG: UV radiation resistance associated gene; VSV: vesicular stomatitis virus; ZFYVE1/DFCP1: zinc finger FYVE-type containing 1.
自噬是一种自我消化的生存途径,在应激反应中被激活,以将货物靶向溶酶体降解。近年来,自噬作为一种先天的抗病毒防御机制而备受关注,通过多种过程,如针对病毒粒子和病毒成分进行消除。这些令人兴奋的发现鼓励了研究自噬对 HIV 的限制作用。然而,自噬在 HIV 感染中的作用仍不清楚。虽然有些报告表明自噬对 HIV 有害,但其他报告则声称 HIV 故意激活这种途径来增加其感染性。此外,这些相互矛盾的发现似乎取决于所研究的细胞类型。在这里,我们表明自噬对 HIV 复制构成障碍,显著减少病毒粒子的产生。然而,HIV-1 利用其辅助蛋白 Nef 来对抗这种限制。先前的研究表明,Nef 通过阻止自噬体与溶酶体融合来影响自噬体的成熟。在这里,我们揭示 Nef 还通过增强 BECN1 与其抑制剂 BCL2 之间的关联来阻止自噬体的起始,这种活性依赖于细胞 E3 连接酶 PRKN。值得注意的是,Nef 对抗自噬阻断的能力在流行的 HIV-1 和感染黑猩猩的其灵长类前体 SIV 中比在感染黑猩猩的 HIV-2 和其灵长类前体 SIV 中更频繁地观察到。总之,我们的研究结果表明 HIV-1 易受自噬限制,并将 Nef 定义为该抗病毒过程的主要自噬拮抗剂。3-MA:3-甲基腺嘌呤;ACTB:肌动蛋白,β;ATG16L1:自噬相关 16 样 1;BCL2:bcl2 凋亡调节剂;BECN1:自噬相关蛋白 16 样 1;cDNA:互补 DNA;EGFP:增强型绿色荧光蛋白;ER:内质网;Gag/p55:群特异性抗原;GFP:绿色荧光蛋白;GST:谷胱甘肽 S 转移酶;HA:血凝素;HIV:人类免疫缺陷病毒;IP:免疫沉淀;MAP1LC3B/LC3B:微管相关蛋白 1 轻链 3β;Nef:负因子;PRKN:Parkin RBR E3 泛素连接酶;PtdIns3K:磷脂酰肌醇 3 激酶;PtdIns3P:磷脂酰肌醇 3 磷酸;PTM:翻译后修饰;RT-qPCR:逆转录定量 PCR;RUBCN:Rubicon 自噬调节剂;SEM:平均值的标准误差;SERINC3:丝氨酸掺入 3;SERINC5:丝氨酸掺入 5;SIV:猿免疫缺陷病毒;SQSTM1/p62:自噬相关蛋白 16 样 1;TFEB:转录因子 EB;UVRAG:UV 辐射抗性相关基因;VSV:水疱性口炎病毒;ZFYVE1/DFCP1:锌指 FYVE 型包含 1。